Skip to main content

Table 1 In vitro antibacterial activities of compounds 8a-q and 11

From: Design, synthesis and antimicrobial evaluation of novel 2-aryl-thiazolidin-4-one derivatives

Compound

R

R 1

R 2

R 3

R 4

R 5

MIC (μg/mL)

       

Ec

Pa

Sa

Kp

8a

H

H

H

H

H

> 50

> 50

50

12.5

8b

H

H

CF3

H

H

> 50

> 50

50

12.5

8c

H

H

Br

H

H

> 50

> 50

50

12.5

8d

H

H

Cl

H

H

> 50

> 50

> 50

12.5

8e

H

H

CH3

H

H

> 50

> 50

> 50

25

8f

H

H

F

H

H

> 50

> 50

> 50

50

8g

CF3

H

H

H

H

> 50

> 50

> 50

> 50

8h

F

F

F

F

F

> 50

> 50

> 50

> 50

8i

H

H

Br

H

H

> 50

> 50

> 50

> 50

8j

H

H

F

H

H

> 50

> 50

> 50

> 50

8k

H

H

Br

H

H

> 50

> 50

> 50

> 50

8l

H

H

CF3

H

H

> 50

> 50

> 50

> 50

8m

H

H

Br

H

H

> 50

> 50

> 50

> 50

8n

H

H

Cl

H

H

> 50

> 50

> 50

> 50

8o

H

Br

H

H

H

> 50

> 50

> 50

> 50

8p

H

Cl

H

H

H

> 50

> 50

> 50

> 50

8q

H

F

H

H

H

50

> 50

> 50

> 50

11

-

-

-

-

-

-

> 50

> 50

> 50

> 50

Gentamycin

-

-

-

-

-

-

0.78

0.78

0.39

0.78

Ampicillin

-

-

-

-

-

-

50

50

0.19

0.39

  1. Ec, E. coli (ATCC 9637); Pa, P. aeruginosa (ATCC BAA-427); Sa, S. aureus (ATCC 25923); Kp, K. pneumonia (ATCC 27736)